| Literature DB >> 31741818 |
Wouter Droog1, D-Yin Lin1, Jan J van Wijk1, Raissah C H Ho-Asjoe1, J Henk Coert2, Robert Jan Stolker1, Eilish M Galvin1.
Abstract
Although numerous studies have addressed the topic of postoperative nerve injury, debate continues to exist on its exact incidence, risk factors, etiology, and functional outcome. The aim of this study is to investigate the incidence of nerve injury and to identify patient, anesthetic, and surgical factors pertaining to perioperative nerve injury. Also, long-term nerve injury outcomes were assessed in terms of functionality.Entities:
Year: 2019 PMID: 31741818 PMCID: PMC6799396 DOI: 10.1097/GOX.0000000000002458
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Characteristics of Patients with and without New Nerve Injury
| No Nerve Injury (n = 283) | Nerve Injury (n = 14) | ||
|---|---|---|---|
| Male (n) | 128 (45.2%) | 3 (21.4%) | 0.101 |
| Female (n) | 155 (54.8) | 11 (78.6%) | |
| Age (years) | 51.3 ± 16.0 | 50.5 ± 14.5 | 0.857 |
| BMI (kg/m2) | 25.0 | 24.6 | 0.452 |
| (IQR) | (23.2 – 28.0) | (22.7 – 27.8) | |
| Diabetes mellitus (yes) | 19 (6.7%) | 0 | 1.000 |
| ASA-classification | 0.509 | ||
| ASA 1 (n) | 127 (44.9%) | 7 (50.0%) | |
| ASA 2 (n) | 146 (51.6%) | 6 (42.9%) | |
| ASA 3 (n) | 10 (3.5%) | 1 (7.1%) |
Data are presented as “valid percentage,” “mean ± SD,” and “median (IQR).”
ASA-classification (class 1–6), according to The ASA classification system.
ASA, The American Society of Anesthesiologists; BMI, body mass index; IQR, interquartile range.
Characteristics of Anesthesia Technique Used in Patients with and without New Nerve Injury
| Total | No Nerve Injury | Nerve Injury | ||
|---|---|---|---|---|
| Type of anesthesia (n) | 297 | 283 | 14 | |
| General anesthesia alone | 92 | 87 (30.7%) | 5 (35.7%) | 0.933 |
| Local anesthesia (surgeon) | 16 | 16 (5.7%) | 0 | |
| Regional anesthesia: | 189 | |||
| Regional block alone | 146 (51.6%) | 9 (64.3%) | ||
| Regional block + general anesthesia (scheduled) | 19 (6.7%) | 0 | ||
| Regional block + general anesthesia (conversion) | 15 (5.3%) | 0 | ||
| Type of regional anesthesia (n) | 189 | 180 | 9 | |
| Non plexus blocks | 40 | 0.452 | ||
| Bier block | 39 (21.6%) | 1 (11.1%) | ||
| Plexus blocks | 149 | |||
| Pippa block | 1 (0.6%) | 0 | ||
| Vertical infraclavicular block | 1 (0.6%) | 0 | ||
| Interscalene block | 3 (1.6%) | 0 | ||
| Supraclavicular block | 18 (10.0%) | 3 (33.3%) | ||
| Axillary plexus block | 118 (65.6%) | 5 (55.6%) | ||
| Plexus blocks details (n)* | 149 | 141 | 8 | |
| Sole use of ultrasound (n) | 32 (22.7%) | 4 (50.0%) | 0.097 | |
| Sole use of nerve stimulator (n) | 15 (10.6%) | 0 | 1.00 | |
| Combined use (n) | 94 (66.7%) | 4 (50.0%) | 0.449 | |
| Threshold nerve stimulator ≤ 0.2mA, at 0.1ms | 10 | 0 | 1.00 | |
| Paresthesia during block placement (yes) | 9 (6.4%) | 0 | 1.00 | |
| Sedation during block placement (yes) | 88 (62.4%) | 5 (62.5%) | 1.00 | |
| Surgical details (n) | 297 | 283 | 14 | |
| Additional block by surgeon or anesthetist | 61 (21.6%) | 2 (14.3%) | 0.314 | |
| Tourniquet use | 274 (96.8%) | 14 (100%) | 1.00 | |
| Tourniquet pressure (mm Hg) | 250 | 250 | 0.751 | |
| (IQR) | (220 – 250) | (223 – 260) | ||
| Duration of tourniquet use (min) | 45.0 | 41.0 | 0.694 | |
| (IQR) | (30 – 65) | (30.0 – 56.0) |
Data are presented as “valid percentage” or “median (IQR).”
*Ultrasound or nerve stimulator are never used in performing the Bier block or local anesthesia and are therefore left out.
IQR.
Type of Surgery Details for Patients with and without New Nerve Injury
| No Nerve Injury (n = 283) | Nerve Injury (n = 14) | ||
|---|---|---|---|
| Arthrodesis/arthroplasty | 34 (12.0%) | 5 (35.7%) | 0.456 |
| Carpal tunnel syndrome | 14 (4.9%) | 1 (7.1%) | |
| Cubital tunnel syndrome | 2 (0.7%) | 0 | |
| Dupuytren’s contracture | 80 (28.3%) | 3 (21.4%) | |
| Finger-joint replacement | 3 (1.1%) | 0 | |
| Ganglion cyst removal | 13 (4.6%) | 0 | |
| Ligament repair surgery | 16 (5.7%) | 0 | |
| Neuroma excision | 4 (1.4%) | 0 | |
| Placement of osteosynthesis material | 4 (1.4%) | 1 (7.1%) | |
| Proximal row carpectomy | 2 (0.7%) | 0 | |
| Quervain’s release surgery | 6 (2.1%) | 1 (7.1%) | |
| Removal of osteosynthesis material | 4 (1.4%) | 0 | |
| Tendon repair surgery | 9 (3.2%) | 0 | |
| Tenolysis | 2 (0.7%) | 1 (7.1%) | |
| Trigger finger release | 12 (4.2%) | 0 | |
| Ulnar nerve transposition | 9 (3.2%) | 0 | |
| Wrist arthroscopy | 19 (6.7%) | 2 (14.3%) | |
| Miscellaneous | 50 (17.7%) | 0 |
Data are presented as “valid percentage.”
Details of All 14 Patients with Nerve Injury
| No. | Medical History | Surgery and Anesthesia Details | Tourniquet | Type of Nerve Injury and Details | Quick-DASH* |
|---|---|---|---|---|---|
| Suspected Surgical Origin of Nerve Injury | |||||
| 1 | PVD: negative/smoking: positive COPD arthrodesis CMC-2/3, with botulin injections for dystonia | Surgery: arthrodesis/arthroplasty | 200 mm Hg 36 min | Signs: dysesthesia (first to thrid finger) | Deceased 5 weeks postoperatively (cardiac cause) |
| 2 | PVD: negative/smoking: negative dupuytren’s contracture (left fifth finger) | Surgery: dupuytren’s contracture | 250 mm Hg 60 min | Signs: dysesthesia in the ulnar side of the fifth finger (UDN paresthesia) | 0%–9% (Decreased functionality) |
| 3 | PVD: negative/smoking: positive hypertension COPD | Surgery: quervain’s release surgery | 280 mm Hg 16 min | Signs: dysesthesia of two nerves in operative field (RSN paresthesia and LABCN neuropraxia) | 56%–59% (Decreased functionality) |
| 4 | PVD: negative/smoking: negative arthrodesis for CMC-1 arthrosis | Surgery: arthrodesis/arthroplasty | 250 mm Hg 41 min | Signs: dysesthesia of the RSN (nerve in surgical field) | 59%–59% (equal functionality) |
| 5 | PVD: negative/smoking: negative hypertension | Surgery: arthrodesis/arthroplasty | 260 mm Hg 40 min | Signs: signs of CRPS and dysesthesia of the RSN | 39%–52% (Decreased functionality) |
| 6 | PVD: negative/smoking: negative arthrodesis MTP-1, complicated by CPRS | Surgery: arthrodesis/arthroplasty | 250 mm Hg 30 min | Signs: RSN allodynia in the direct operative field | 75%–41% (Increased functionality) |
| 7 | PVD: negative/smoking: negative right-sided carpal tunnel release, complicated by neuropraxia | Surgery: carpal tunnel syndrome | 250 mm Hg 35 min | Signs: dysesthesia (fourth and fifth finger) | 39%–21% (Increased functionality) |
| 8 | PVD: negative/smoking: negative traumatic amputation of the distal part of the second finger, without neurological deficits | Surgery: miscellaneous | 200 mm Hg 17 min | Signs: RDN paresthesia (first to third finger) | 23%–5% (Increased functionality) |
| 9 | PVD: negative/smoking: negative no relevant history | Surgery: miscellaneous | 230 mm Hg 45 min | Signs: dysesthesia (fifth finger) | 34%–43% (Decreased functionality) |
| 10 | PVD: negative/smoking: negative carpal tunnel release | Surgery: arthrodesis/arthroplasty | 260 mm Hg 135 min | Signs: dysesthesia (second to fifth finger), partly due to tight cast | 50%–36% (Increased functionality) |
| 11 | PVD: negative/smoking: negative hypertension prosthetic aortic valve and coronary artery stenting | Surgery: dupuytren’s contracture | 220 mm Hg 40 min | Signs: signs of CRPS and dysesthesia (second finger) | 14%–16% (Decreased functionality) |
| Suspected anesthetic origin of nerve injury | |||||
| 12 | PVD: negative/smoking: negative no relevant history | Surgery: wrist arthroscopy | 250 mm Hg 50 min | Signs: dysesthesia (first to fourth finger) | Lost to follow-up |
| 13 | PVD: negative/smoking: negative hypertension sacral nerve stimulator for an overactive bladder | Surgery: wrist arthroscopy | 250 mm Hg 56 min | Signs: paresthesia (second to fourth finger), nerve not in the surgical field | 68%–50% (Increased functionality) |
| Inconclusive origin of nerve injury | |||||
| 14 | PVD: negative/smoking: negative no relevant history | Surgery: dupuytren’s contracture | 280 mm Hg 50 min | Signs: signs of CRPS and paresthesia (second and third finger) | 21%–11% (Improved functionality) |
Quick DASH scores preoperatively, and at 4 years following surgery; with 0%–20% normal function 20–40% mild disability, 40%–60% moderate disability, 60%–80% severe disability.
ABPB, axillary brachial plexus block; CMC, carpometacarpal joint; CRPS, complex regional pain syndrome; EMG, electromyography; LABCN, lateral antebrachial cutaneous nerve; MTP, metatarsophalangeal joint; NS, nerve stimulator; PVD, peripheral vascular diseases; RDN, radial digital nerve; RSN, radial sensory nerve; SCBPB, supraclavicular brachial plexus block; UDN, ulnar digital nerve; US, ultrasound.